Vanguard Group Inc Cytek Biosciences, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,012,805 shares of CTKB stock, worth $67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,012,805

Previous 11,890,700 1.03%

Holding current value

$67 Million

Previous $108 Million 25.67%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$6.29 - $9.15 $768,040 - $1.12 Million	122,105 Added 1.03%	12,012,805 $80.6 Million
Q4 2023 Feb 14, 2024	BUY	$4.1 - $9.51 $3.33 Million - $7.72 Million	811,279 Added 7.32%	11,890,700 $108 Million
Q3 2023 Nov 14, 2023	BUY	$5.52 - $9.5 $2.55 Million - $4.38 Million	461,142 Added 4.34%	11,079,421 $61.2 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $18.3 Million - $32.8 Million	2,732,791 Added 34.66%	10,618,279 $90.7 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.47 $965,713 - $1.54 Million	114,421 Added 1.47%	7,885,488 $72.5 Million

Q4 2022 Feb 10, 2023	BUY	$9.71 - $15.86 $811,387 - $1.33 Million	83,562 Added 1.09%	7,771,067 $79.3 Million
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $15.5 Million - $21.8 Million	1,413,703 Added 22.53%	7,687,505 $113 Million
Q2 2022 Aug 12, 2022	SELL	$7.41 - $11.56 $580,114 - $905,009	-78,288 Reduced 1.23%	6,273,802 $67.3 Million
Q1 2022 May 13, 2022	BUY	$9.89 - $17.25 $50.8 Million - $88.7 Million	5,140,344 Added 424.21%	6,352,090 $68.5 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $25.04 $248,136 - $384,964	15,374 Added 1.29%	1,211,746 $19.8 Million
Q3 2021 Nov 12, 2021	BUY	$17.52 - $27.93 $21 Million - $33.4 Million	1,196,372 New	1,196,372 $25.6 Million

Others Institutions Holding CTKB

# of Institutions

121

Shares Held

72.5M

Call Options Held

13.2K

Put Options Held

31.2K

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $751M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cytek Biosciences, Inc. Transaction History